Oestradiol post-functionalized gold(i) bis(1,2,3-triazol-5-ylidene) complex exhibits high activity for ERα-positive breast cancer cells (MCF-7)

Abstract

Au(I) N-heterocyclic carbene (NHC) complexes have shown promising cytotoxicity against cancer cells, yet improving their selectivity remains a key challenge. In this study, a modular strategy to enhance tumor targeting by post-functionalizing an Au(I) bis-aNHCtrz complex (trz = 1,2,3-triazole-5-ylidene) with oestradiol via copper-catalyzed click chemistry is introduced. The resulting conjugate shows high cytotoxicity in the nanomolar range and markedly increased accumulation in ERα-positive breast cancer cells compared to its non-functionalized analogue. This work demonstrates the potential of hormone-based vectors to guide gold complexes selectively to hormone receptor-positive cancer cells.

Graphical abstract: Oestradiol post-functionalized gold(i) bis(1,2,3-triazol-5-ylidene) complex exhibits high activity for ERα-positive breast cancer cells (MCF-7)

Supplementary files

Article information

Article type
Paper
Submitted
25 Jul 2025
Accepted
01 Dec 2025
First published
08 Dec 2025
This article is Open Access
Creative Commons BY license

Dalton Trans., 2026, Advance Article

Oestradiol post-functionalized gold(I) bis(1,2,3-triazol-5-ylidene) complex exhibits high activity for ERα-positive breast cancer cells (MCF-7)

M. E. Hoffmann, F. Marques, J. D. G. Correia and F. E. Kühn, Dalton Trans., 2026, Advance Article , DOI: 10.1039/D5DT01763G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements